proved that CD44 standard splice isoform can activate the PDGFRβ/Stat3 cascade and induce the cancer stem cell traits, which indicates that CD44 could be a potential target in inhibiting the progress of breast cancer (9). This evidence concerns the gene CD44 and breast cancer.